Back
Regeneron Pharmaceuticals 10K Form
Buy
56
REGN
Regeneron Pharmaceuticals
Last Price:
1,015.67
Seasonality Move:
10.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
2023-11-02 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
2023-08-03 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
2023-05-04 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
2022-11-03 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
2022-08-03 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
Receive REGN News And Ratings
See the #1 stock for the next 7 days that we like better than REGN
REGN Financial Statistics
Sales & Book Value
Annual Sales: | $13.12B |
---|---|
Cash Flow: | $143.1M |
Price / Cash Flow: | 36.49 |
Annual Sales: | $255.99 |
Price / Book: | 3.97 |
Profitability
EPS (TTM): | 37.76000 |
---|---|
Net Income (TTM): | $4.32B |
Gross Margin: | $11.3B |
Return on Equity: | 16.61% |
Return on Assets: | 12.99% |
Regeneron Pharmaceuticals Earnings Forecast
Key Regeneron Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 34 years for REGN is 86.16%.
- The Selling, General & Administrative Expenses for REGN have been equal to 20.06% of Gross Profit Margin.
- The Research & Development expenses have been 33.84% of Revenue.
- The Interest Expense is 1.85% of Operating Income.
- The Net Earning history of REGN is 30.14% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 18 years.
Regeneron Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | REGN |
CUSIP: | 75886F |
Website: | regeneron.com |
Debt
Debt-to-Equity Ratio: | 0.07 |
---|---|
Current Ratio: | 5.44 |
Quick Ratio: | 4.43 |
Price-to-Earnings
Trailing P/E Ratio: | 29.21 |
---|---|
Forward P/E Ratio: | 21 |
REGN Technical Analysis vs Fundamental Analysis
Buy
56
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a Buy
The current Regeneron Pharmaceuticals [REGN] share price is $1,015.67. The Score for REGN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.